Valmir Rastely-Junior | Infectious Diseases | Young Scientist Award

Published on 09/10/202509/10/2025 by NESIN Awards

Mr. Valmir Rastely-Junior | Infectious Diseases | Young Scientist Award

Universidade Federal da Bahia | Brazil

Mr. Valmir Rastely-Junior is a distinguished physician specializing in infectious diseases, pediatrics, and neuropediatrics, with an MD from the Federal University of Bahia (UFBA, 2015). He has accumulated extensive clinical and research experience, focusing on child health, congenital Zika syndrome, antimicrobial resistance, and public health inequities, integrating multidisciplinary care with evidence-based interventions. His professional trajectory includes work at Fiocruz Bahia on neurodevelopmental studies, epidemiologic surveillance, teratogen information services, and COVID-19 teleadvice programs. He has been instrumental in technology-driven initiatives such as Telecoronavírus (UFBA) and Artificial Intelligence as a Service for Combating COVID-19 (Rede CoVida/Cidacs Fiocruz), emphasizing the translation of research into practical, community-focused solutions. Mr. Rastely-Junior’s research interests center on infectious-disease–driven child health, neurodevelopmental outcomes in congenital infections, health disparities, and AI-supported clinical and epidemiological tools. He possesses strong research skills, including clinical study design, epidemiologic analysis, bibliometric synthesis, and international collaborative research, demonstrated through six peer-reviewed publications in Scopus and PubMed-indexed journals, three joint research projects, two conference presentations, and mentorship of research scholars. His work has earned eight awards and recognitions, including first-place honors at Fiocruz Bahia and an honorable mention in the International Balint Award/Ascona Prize, reflecting both scientific excellence and societal impact. Mr. Rastely-Junior is an active member of 16 professional bodies, contributing to editorial, review, and volunteer initiatives that promote knowledge dissemination and community engagement. In conclusion, his blend of clinical expertise, innovative research, international collaborations, and commitment to evidence-based public health positions him as a promising leader in global biomedical research, capable of advancing high-impact publications, AI-enabled solutions, and mentorship programs that enhance healthcare outcomes and scientific standards worldwide. 27 Citations | 3 Documents | 2 h-index.

Profiles: Google Scholar | Scopus | ORCID | LinkedIn

Featured Publications

Aguilar Ticona, J. P., Nery Jr, N., Doss-Gollin, S., Gambrah, C., Lessa, M., … Rastely-Junior, V. N. (2021). Heterogeneous development of children with Congenital Zika Syndrome-associated microcephaly. PLoS One, 16(9), e0256444. https://doi.org/10.1371/journal.pone.0256444. Cited by: 26
Nery Jr, N., Aguilar Ticona, J. P., Gambrah, C., Doss-Gollin, S., Aromolaran, A., … Rastely-Junior, V. N. (2021). Social determinants associated with Zika virus infection in pregnant women. PLoS Neglected Tropical Diseases, 15(7), e0009612. https://doi.org/10.1371/journal.pntd.0009612. Cited by: 14
Aromolaran, A., Araujo, K., Ladines-Lim, J. B., Nery Jr, N., do Rosário, M. S., … Rastely-Junior, V. N. (2022). Unequal burden of Zika-associated microcephaly among populations with public and private healthcare in Salvador, Brazil. International Journal of Infectious Diseases, 120, 201–204. https://doi.org/10.1016/j.ijid.2022.06.021. Cited by: 6
Mattos, A. M., Rastely-Junior, V. N., Pires, M. M., Aguilar, J. P., Lessa, M. S. A., Regis, C., … (2023). Predictors of neurodevelopment in microcephaly associated with congenital Zika Syndrome: A prospective study. Children, 10(12), 1831. https://doi.org/10.3390/children10121831. Cited by: 3
Brito, L. B., Rastely-Junior, V. N., Browne, E. S., Nery Júnior, N. R. R., … (2016). Sinais e sintomas de zika-virus em gestantes internadas em um Hospital Público de referência da Bahia. Cited by: 2

Sergey Suchkov | Clinical Immunology | Excellence in Innovation Award

Published on 09/10/202509/10/2025 by NESIN Awards

Prof. Sergey Suchkov | Clinical Immunology | Excellence in Innovation Award

Professor in Medicine and Immunology | N.D. Zelinskii Institute for Organic Chemistry | Russia

Prof. Sergey V. Suchkov, MD, PhD, is a distinguished physician-scientist and international leader in immunology, personalized and precision medicine, and biodesign. Born in Astrakhan, Russia, he graduated with an MD from Astrakhan State Medical University in 1980 and earned his PhD from Sechenov University in 1985, followed by a Doctor’s Degree from the National Institute of Immunology in 2002. His professional experience spans over four decades, including senior research positions at the USSR Academy of Medical Sciences, the Moscow Clinical Research Institute (MONIKI), and leadership roles as Director of the Center for Personalized & Precision Medicine at Sechenov University, Vice-Director of the Institute for Biotech & Global Health at RosBioTech National University, and Director of the Center for Biodesign at N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences. He has contributed to international collaborations, with advanced training and research engagements at the NEI, NIH, USA, Wills Eye Hospital, Philadelphia, and invited work at several British universities under the Royal Society for Immunology. Prof. Suchkov’s research interests include clinical immunology, predictive and preventive medicine, precision nutrition, and translational biodesign, underpinned by skills in immunobiotechnology, personalized therapy design, clinical trial management, and biomedical innovation. He has authored numerous publications in reputed journals and conferences (IEEE, Scopus-indexed) and actively participates in global professional societies including EPMA, ISPM, PMC, ACS, AHA, ARVO, ISER, and AMEE. Recognized for his leadership and contributions to medical education and clinical practice, he has received multiple honors and holds key advisory roles in international research organizations. Prof. Suchkov’s exceptional expertise, global collaborations, and mentorship capacity position him to advance personalized medicine and immunology research worldwide, foster innovation, and continue contributing to healthcare and scientific communities at the highest level, making him a highly deserving candidate for recognition and awards in his field. 989 Citations | 87 Documents | 12 h-index.

Profiles: Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

Suchkov, S. V., Revishvili, A. S., Charchyan, E. R., & Belov, Y. V. (2025). Towards highly precise treatment and rehabilitation in practice of modern cardiologist, cardiac surgeon and cardiac rehabilitation professional.
Suchkov, S. V., Charchyan, E. R., Polyakova, V. N., & Belov, Y. V. (2025). On the path to personalized cardiology: prospects of precise assessment of cardiovascular risks and predictive-prognostic diagnostics.
Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Human Health, Environmental Comfort and Well-Being. Part 2. Ecological Comfort as a New and Strategic Factor in the Protection of Modern Human Health.
Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Human Health, Environmental Comfort and Well-Being. Part 1. Engineering and Design Resources of the Bioindustry on the Way to Safe Competition with the Resources of Natural Biocenoses and Health-Saving Systems.
Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Health, Environmental Comfort and Wellbeing through the Integration of Natural and Engineering-Design Bioresources: At the Junction of Pharmaco- and Nutriodesign to the Bioindustry of Tomorrow.

Kausik Paul | Immunology and Microbiology | Best Researcher Award

Published on 06/06/202506/06/2025 by NESIN Awards

Dr . Kausik Paul | Immunology and Microbiology | Best Researcher Award

Project Scientist at Cedars-Sinai Medical Center , United States

Dr. Kausik Paul is a dedicated immunologist and project scientist at Cedars-Sinai Medical Center, specializing in red blood cell (RBC) alloimmunization and transfusion medicine. With a strong academic foundation in microbiology, biophysics, and immunology, he has contributed significantly to understanding immune responses in lupus and transfusion settings. His work includes notable first-author publications in Frontiers in Immunology and Antioxidants, as well as multiple conference presentations on alloantibody responses in lupus mouse models. Dr. Paul has a strong history of scientific productivity, including peer-reviewed publications, patents, and impactful collaborative research. His technical expertise spans flow cytometry, cytokine profiling, and qPCR, supporting his efforts to refine personalized transfusion protocols. While he could further enhance his profile by securing independent funding and leading larger-scale projects, his current contributions reflect originality, depth, and clinical relevance. Dr. Paul is a highly suitable candidate for the Best Researcher Award, with clear potential for continued impactful research.

Professional Profile

Google Scholar

Education🎓

Dr. Kausik Paul has a comprehensive and interdisciplinary educational background that has shaped his expertise in immunology and transfusion medicine. He began his academic journey with a Bachelor of Science in Microbiology, followed by a Master’s degree in Biophysics from Dr. Babasaheb Ambedkar Marathwada University, Aurangabad. His growing interest in immune mechanisms led him to pursue a Ph.D. in Infectious Diseases and Immunology at IICB-CSIR and Jadavpur University, Kolkata, where he developed a strong foundation in antigen-antibody interactions and immune response regulation. To further expand his knowledge, Dr. Paul completed postdoctoral training in immunology at the University of Manitoba and the University of Arizona, gaining exposure to advanced immunological techniques and research models. His education has been integral to his development as a researcher, equipping him with the scientific rigor and technical skills necessary to investigate complex immune responses, particularly in the context of RBC alloimmunization and autoimmune conditions like lupus.

Professional Experience📝

Dr. Kausik Paul has amassed extensive professional experience in immunology, with a focus on transfusion medicine and red blood cell (RBC) alloimmunization. Currently serving as a Project Scientist at Cedars-Sinai Medical Center since 2022, he leads research exploring immune responses to RBC antigens, particularly in lupus models. Prior to this, he held faculty positions as an Assistant Professor at Seacom Skills University and Glocal University, where he was involved in both teaching and research. His earlier postdoctoral appointments at the University of Manitoba and the University of Arizona enriched his expertise in cellular immunology and advanced laboratory techniques. Throughout his career, Dr. Paul has demonstrated a strong command of experimental approaches such as flow cytometry, cytokine profiling, and qPCR. His roles have included both independent and collaborative research, manuscript writing, and conference presentations. These experiences have collectively positioned him as a skilled and impactful researcher in the field of immunological science.

Research Interest🔎

Dr. Kausik Paul’s research interests lie primarily in immunology, with a specialized focus on red blood cell (RBC) alloimmunization, autoimmune disorders, and transfusion medicine. He is particularly interested in understanding the molecular and cellular mechanisms behind alloantibody formation in response to RBC antigens, especially in autoimmune conditions such as lupus. His current research explores the roles of type 1 and type 2 interferons in modulating immune responses to transfused RBCs, aiming to develop personalized transfusion strategies that minimize alloimmunization risk. Dr. Paul is also deeply invested in investigating inflammatory cytokine profiles, interferon-stimulated gene expression, and antigen presentation processes. His long-term goal is to translate basic immunological findings into clinically applicable solutions that enhance patient outcomes during blood transfusion therapies. Through the integration of advanced immunological techniques and animal models, Dr. Paul aspires to contribute significantly to the field of transfusion science and improve therapeutic protocols for immunocompromised

Award and Honor🏆

Dr. Kausik Paul has been recognized with several prestigious awards and honors throughout his academic and research career, reflecting his dedication and contributions to the field of immunology. He was the recipient of the Senior Research Fellowship (SRF) from the Council of Scientific and Industrial Research (CSIR), India, in 2007, which is awarded to outstanding doctoral candidates in scientific research. In 2006, he was also granted a Senior Research Fellowship through a project funded by the Department of Biotechnology (DBT), India, underscoring his involvement in high-impact research initiatives. Earlier, in 2003, Dr. Paul received a Research Fellowship under a project funded by the Department of Science and Technology (DST), India, during the initial stages of his research career. These honors not only highlight his scientific capabilities but also demonstrate the recognition he has earned from national funding agencies for his commitment to advancing biomedical research and innovation in immunology and related fields.

Research Skill🔬

Dr. Kausik Paul possesses a comprehensive range of research skills that span basic and translational immunology, with a strong emphasis on red blood cell (RBC) alloimmunization and autoimmune disease models. He is highly proficient in advanced laboratory techniques, including flow cytometry for cellular analysis and crossmatching, quantitative PCR for gene expression profiling, and ELISA-based assays for measuring cytokines and immune responses. His expertise extends to in vivo experimental design using mouse models, particularly in lupus research, where he investigates type 1 and type 2 interferon pathways and their influence on alloantibody production. Dr. Paul also demonstrates strong analytical skills in data interpretation, experimental troubleshooting, and scientific writing, as evidenced by his numerous publications and conference presentations. His ability to integrate immunological theory with practical experimentation has been instrumental in uncovering novel insights into transfusion medicine. Collectively, his technical competencies and critical thinking make him a valuable contributor to biomedical research.

Conclusion💡

Dr. Kausik Paul demonstrates a strong case for the Best Researcher Award, especially within the domains of transfusion medicine and immunology. He has a proven track record of impactful research, interdisciplinary collaboration, innovation (patents), and consistent engagement with the global scientific community through publications and conferences.

While there are areas he can build on—especially independent funding, mentorship, and institutional leadership—his current trajectory and recent accomplishments, particularly in a high-impact field like lupus-related RBC alloimmunization, are highly commendable.

Publications Top Noted✍

Title: Activated T lymphocytes migrate toward the cathode of DC electric fields in microfluidic devices
Authors: J Li, S Nandagopal, D Wu, SF Romanuik, K Paul, DJ Thomson, F Lin
Year: 2011
Citations: 91
Title: N-acetyl cysteine enhances imatinib-induced apoptosis of Bcr-Abl⁺ cells by endothelial nitric oxide synthase-mediated production of nitric oxide
Authors: S Rakshit, J Bagchi, L Mandal, K Paul, D Ganguly, S Bhattacharjee, …
Year: 2009
Citations: 48
Title: Leishmania donovani Infection of Human Myeloid Dendritic Cells Leads to a Th1 Response in CD4⁺ T Cells from Healthy Donors and Patients with Kala-Azar
Authors: M Ghosh, L Mandal, S Maitra, S Rakshit, K Paul, J Bagchi, D Ganguly, …
Year: 2006
Citations: 30
Title: Granulocyte–macrophage colony‐stimulating factor drives monocytes to CD14^low CD83⁺ DCSIGN⁻ interleukin‐10‐producing myeloid cells with differential …
Authors: D Ganguly, K Paul, J Bagchi, S Rakshit, L Mandal, G Bandyopadhyay, …
Year: 2007
Citations: 26
Title: Chromone linked nitrone derivative induces the expression of iNOS2 and Th1 cytokines but reduces the Th2 response in experimental visceral leishmaniasis
Authors: S Mallick, S Halder, A Dutta, S Dey, K Paul, S Maiti, C Bandyopadhyay, …
Year: 2013
Citations: 22
Title: Dendritic cells and antigen trapping technology—a revolution in vaccine/immunotherapy strategy
Authors: C Pal, D Ganguly, K Paul, S Pal
Year: 2007
Citations: 5
Title: Distinct RBC alloantibody responses in type 1 interferon-dependent and -independent lupus mouse models
Authors: K Paul, R Hernández-Armengol, JY Lee, CY Chang, T Shibata, …
Year: 2024
Citations: 3
Title: Inhibitors of phosphatidylinositol-3-kinase (PI3) and inducers of nitric oxide (NO)
Authors: S Bandyopadhyay, BC Pal, J Parasuraman, S Roy, JB Chakrabotry, …
Year: 2016
Citations: 1
Title: Expression of Concern: Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species‐dependent …
Authors: JB Chakraborty, SK Mahato, K Joshi, V Shinde, S Rakshit, N Biswas, …
Year: 2012
Citations: 1

Iram Iqbal | Cardiovascular Pharmacology | Best Researcher Award

Published on 26/05/202526/05/2025 by NESIN Awards

Ms. Iram Iqbal | Cardiovascular Pharmacology | Best Researcher Award

PHD Scholar at Department of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University, Pakistan

Dr. Iram Iqbal, a dedicated pharmacology researcher and academic, has made significant contributions to ethnopharmacology, pharmaceutical quality assurance, and drug development. With a Pharm.D., M.Phil., and ongoing Ph.D. from Bahauddin Zakariya University, her research explores the pharmacological potential of medicinal plants and modern drug delivery mechanisms. She has served in multiple professional roles, including as a Drug Analyst at the Primary & Secondary Healthcare Department and as a lecturer, demonstrating expertise in pharmaceutical instrumentation and quality control aligned with ISO 17025 standards. Dr. Iqbal has published extensively in peer-reviewed journals, contributed book chapters, and presented at numerous national and international conferences. Her technical proficiency with instruments such as HPLC, GC-MS, and FTIR, coupled with her strong communication and organizational skills, underscores her commitment to scientific excellence. Passionate about continuous learning and societal impact, she stands as a strong candidate for the Best Researcher Award, though further international collaborations could enhance her global academic reach.

Professional Profile

Education🎓

Dr. Iram Iqbal has pursued a progressive and research-oriented academic path in the field of pharmacology. She earned her Doctor of Pharmacy (Pharm.D.) degree in 2010 from Bahauddin Zakariya University (BZU), Multan, Pakistan, laying a solid foundation in pharmaceutical sciences. Driven by a passion for research, she completed her M.Phil. in Pharmacology from the same institution in 2015, during which she deepened her understanding of drug mechanisms and medicinal plant pharmacology. Currently, she is enrolled in a Ph.D. program in Pharmacology at BZU, where her research focuses on exploring bioactive compounds in medicinal plants and their therapeutic potentials. Her education has been marked by academic excellence, practical exposure, and a commitment to integrating traditional medicine with modern pharmacological techniques. Throughout her academic journey, Dr. Iqbal has demonstrated a consistent dedication to advancing knowledge in pharmaceutical sciences, positioning herself as a capable researcher and educator in the evolving field of pharmacology.

Professional Experience📝

Dr. Iram Iqbal has accumulated over a decade of professional experience in academia and research, primarily in the field of pharmacology. She began her career as a Lecturer in the Department of Pharmacology at the Faculty of Pharmacy, Bahauddin Zakariya University (BZU), Multan, where she has played a vital role in teaching and mentoring pharmacy students. Her professional journey is marked by a strong emphasis on research, particularly in the areas of medicinal plants, pharmacological screening, and drug safety. Dr. Iqbal has been actively involved in supervising undergraduate and postgraduate research projects, contributing to the development of new insights in pharmacology. Her work also includes collaborations on national and international research projects, participation in scientific conferences, and the publication of several research articles in peer-reviewed journals. Her blend of academic teaching and hands-on research experience has established her as a respected professional committed to advancing pharmaceutical education and therapeutic innovation.

Research Interest🔎

Dr. Iram Iqbal’s research interests lie at the intersection of pharmacology, natural product research, and drug safety. She is particularly passionate about exploring the pharmacological properties of medicinal plants and evaluating their therapeutic potential in treating various diseases. Her focus includes the isolation and characterization of bioactive compounds, understanding their mechanisms of action, and assessing their efficacy and toxicity through preclinical studies. Dr. Iqbal is also interested in the pharmacovigilance and safety profiles of both conventional and herbal medicines, aiming to ensure their safe use in clinical practice. Her work often integrates traditional knowledge with modern scientific techniques, promoting evidence-based validation of herbal remedies. She has contributed significantly to the field through her research publications, and her projects often address contemporary health challenges, such as metabolic disorders, inflammation, and infectious diseases. Through her innovative and multidisciplinary approach, Dr. Iqbal seeks to contribute to the development of safer and more effective therapeutic agents.

Award and Honor🏆

Dr. Iram Iqbal has received several awards and honors in recognition of her outstanding contributions to pharmaceutical sciences and education. Her dedication to academic excellence and impactful research has earned her prestigious accolades at both national and institutional levels. She has been honored with research appreciation certificates and excellence awards from renowned academic bodies and universities. Her scholarly work, particularly in the field of pharmacology and natural product research, has been acknowledged through best paper awards and invitations to present at esteemed scientific conferences. In addition to her research achievements, Dr. Iqbal has been recognized for her exceptional teaching and mentorship, guiding numerous students in their academic and professional journeys. Her commitment to advancing pharmaceutical education and her role in shaping future scientists and researchers have further strengthened her reputation in the academic community. These honors reflect her dedication, integrity, and impact in both research and teaching within the field of pharmacy.

Research Skill🔬

Dr. Iram Iqbal possesses a diverse and robust set of research skills that reflect her expertise in pharmaceutical sciences and pharmacology. She is proficient in designing and conducting both in vitro and in vivo experiments, particularly in the evaluation of natural products for therapeutic use. Her skills include phytochemical screening, drug formulation development, pharmacological activity assessment, and toxicity profiling. Dr. Iqbal is well-versed in utilizing advanced laboratory techniques such as chromatography, spectrophotometry, and microscopy. She also demonstrates strong capabilities in data analysis using statistical software, ensuring accurate interpretation and presentation of research findings. Her ability to conduct systematic literature reviews and synthesize existing knowledge into innovative research proposals highlights her analytical thinking. Moreover, she excels in academic writing, having authored multiple peer-reviewed publications. Her collaborative skills and experience in multidisciplinary research projects further strengthen her ability to contribute meaningfully to scientific advancements in the field of pharmaceutical and biomedical research.

Conclusion💡

Dr. Iram Iqbal possesses a robust academic foundation, diverse research contributions, technical expertise, and a strong national impact, making her highly suitable for the Best Researcher Award. While her portfolio is already compelling, strategic enhancements—particularly in international collaborations, publication strategy, and funding leadership—could further elevate her profile globally.

Publications Top Noted✍️

Iqbal, I., Ali, M. A. M., Saqib, F., Alamgir, K., Mubarak, M. S., Chaudhary, A. A., El-Shazly, M., & El-Nashar, H. A. S. (2025). Comprehensive GC-MS profiling and multi-modal pharmacological evaluations of Haloxylon griffithii: In vitro and in vivo approaches. Pharmaceuticals, 18(6), Article 770. https://doi.org/10.3390/ph18060770

Citation Index: Not available yet (published May 22, 2025; newly released).
Iqbal, I., Wilairatana, P., Saqib, F., Nasir, B., Wahid, M., Latif, M. F., Iqbal, A., Naz, R., & Mubarak, M. S. (2023). Plant polyphenols and their potential benefits on cardiovascular health: A review. Molecules, 28(17), 6403. https://doi.org/10.3390/molecules28176403

Citation Index: According to Crossref, this article has 9 citations as of now.

Padmanabha Rao Amarachinta | Pharmacology and Nanotechnology | Leading Innovations in Science Award

Published on 23/04/202523/04/2025 by NESIN Awards

Prof. Padmanabha Rao Amarachinta | Pharmacology and Nanotechnology | Leading Innovations in Science Award

Professor and Deputy Registrar at Anurag University, India

Dr. Padmanabha Rao Amarachinta, Professor and Deputy Registrar at Anurag University, Hyderabad, is a distinguished scholar in pharmaceutical sciences with over 23 years of experience in teaching, research, and industry. He holds a Ph.D. in Toxicology and has conducted advanced research at premier Indian institutions like IICT, CCMB, and NIN. Dr. Rao has published over 35 high-impact papers and authored several book chapters, notably in the area of nanomedicine. His innovations in drug delivery systems, particularly intranasal delivery of Rizatriptan, have earned him both Indian and German patents. He is a recipient of numerous awards including the “Distinguished Scientist Award” and “Leading Educationist of India.” His research interests include nanotechnology, drug discovery, and clinical research, and he is actively involved in mentoring Ph.D. scholars. Dr. Rao’s impactful contributions and leadership in pharmaceutical research make him a strong candidate for the Leading Innovations in Science Award.

Professional Profile

Education🎓

Dr. Padmanabha Rao Amarachinta possesses a strong academic background in pharmaceutical sciences, culminating in a Ph.D. in Toxicology. His educational journey laid a solid foundation for his research and teaching career, with a focus on drug delivery systems and nanomedicine. Throughout his academic training, Dr. Rao demonstrated a keen interest in toxicology and pharmacology, which guided his doctoral research and subsequent scientific contributions. His advanced studies were complemented by research collaborations with prestigious Indian institutes such as the Indian Institute of Chemical Technology (IICT), Centre for Cellular and Molecular Biology (CCMB), and the National Institute of Nutrition (NIN), where he further deepened his expertise in biomedical sciences. His academic achievements reflect a rigorous and interdisciplinary approach to science, combining theoretical knowledge with practical research applications. Dr. Rao’s educational foundation continues to influence his innovative work in pharmaceutical technology, toxicology, and clinical research, enabling him to mentor scholars and contribute to cutting-edge scientific advancements.

Professional Experience📝

Dr. Padmanabha Rao Amarachinta brings over 17 years of diverse professional experience in academia and research, specializing in pharmaceutical sciences and toxicology. He has held significant academic positions, notably serving as an Associate Professor in the Department of Pharmacy at GITAM Deemed to be University. Dr. Rao has been instrumental in designing and delivering advanced curricula in pharmacology and toxicology, mentoring postgraduate and Ph.D. scholars, and fostering a research-driven academic environment. His professional journey includes collaborative research projects with prestigious institutions such as the Indian Institute of Chemical Technology (IICT), Centre for Cellular and Molecular Biology (CCMB), and National Institute of Nutrition (NIN). He has contributed to numerous national and international journals, reflecting his strong research acumen. Dr. Rao’s career highlights his commitment to academic excellence, interdisciplinary research, and innovation in drug delivery systems, making him a respected figure in both academic and scientific communities.

Research Interest🔎

Dr. Padmanabha Rao Amarachinta’s research interests lie primarily in the fields of pharmacology, toxicology, and drug delivery systems, with a special focus on the evaluation of herbal and synthetic drugs for their therapeutic efficacy and safety. He is particularly interested in the pharmacodynamic and pharmacokinetic profiling of novel drug candidates, including natural products with potential pharmacological activity. Dr. Rao explores innovative drug delivery mechanisms to enhance the bioavailability and targeted action of therapeutic agents, aiming to reduce side effects and improve patient outcomes. His research also delves into preclinical toxicological evaluations and the mechanisms of drug-induced organ toxicity. He is passionate about bridging traditional medicinal knowledge with modern pharmacological approaches through scientific validation of herbal formulations. With collaborations across premier research institutions, his work contributes significantly to advancements in evidence-based medicine and the development of safer, more effective treatment options for chronic and acute conditions.

Award and Honor🏆

Dr. Padmanabha Rao Amarachinta has received numerous awards and honors in recognition of his outstanding contributions to pharmaceutical sciences and academic excellence. He has been honored with prestigious fellowships and accolades from reputed institutions, highlighting his dedication to research and innovation in pharmacology and toxicology. Among his notable recognitions are awards for best research paper presentations at national and international conferences, acknowledging the scientific impact and quality of his work. He has also received institutional awards for his commitment to teaching and mentoring students, fostering a collaborative and intellectually stimulating academic environment. His contributions to the field have earned him invitations to serve as a keynote speaker and session chair at several scientific events. These honors reflect not only his professional achievements but also his influence in shaping the next generation of researchers and healthcare professionals, reinforcing his status as a respected figure in the pharmaceutical and biomedical research community.

Research Skill🔬

Dr. Padmanabha Rao Amarachinta possesses a comprehensive set of research skills that span across pharmaceutical sciences, pharmacology, and toxicology. His expertise lies in experimental design, data analysis, and interpretation, particularly in preclinical and in vitro models used for drug evaluation and safety profiling. He is highly skilled in molecular biology techniques, including PCR, ELISA, and Western blotting, which he employs in elucidating mechanisms of drug action and toxicity. Dr. Amarachinta is adept at handling laboratory instruments and software for statistical and bioinformatics analysis, facilitating accurate and reproducible research outcomes. His ability to draft scientific manuscripts, research proposals, and grant applications showcases his proficiency in academic writing and communication. Additionally, he has guided numerous postgraduate students, demonstrating his capability in mentoring and collaborative research. His methodical approach, critical thinking, and problem-solving abilities significantly contribute to his success in advancing pharmaceutical research and generating impactful scientific knowledge.

Conclusion💡

Dr. Padmanabha Rao Amarachinta exhibits strong qualifications for the Leading Innovations in Science Award. His deep-rooted contributions in nanomedicine, high-impact publications, international patents, and academic leadership make him a compelling nominee. He is a proven innovator in pharmaceutical sciences with an impressive blend of academic, research, and administrative excellence.

With minor emphasis on commercialization, global project leadership, and science communication, his already remarkable portfolio could be elevated to even greater heights.

Publications Top Noted✍️

Title: Central composite design for the development of carvedilol-loaded transdermal ethosomal hydrogel for extended and enhanced anti-hypertensive effect
Authors: PR Amarachinta, G Sharma, N Samed, AK Chettupalli, M Alle, JC Kim
Year: 2021
Citations: 77
Title: Design, formulation, in-vitro and ex-vivo evaluation of atazanavir loaded cubosomal gel
Authors: AK Chettupalli, M Ananthula, PR Amarachinta, V Bakshi, VK Yata
Year: 2021
Citations: 51
Title: Pharmacological evaluation of herbal extracts for their in-vitro hypoglycemic activity
Authors: AP Rao, KJ Kaiser Jamil
Year: 2011
Citations: 32
Title: Comparative toxicity of tetra ethyl lead and lead oxide to earthworms, Eisenia fetida (Savigny)
Authors: JV Rao, P Kavitha, AP Rao
Year: 2003
Citations: 24
Title: Design, development and optimization of solid lipid nanoparticles of rizatriptan for intranasal delivery: in-vitro & in-vivo assessment
Authors: V Bakshi, PR Amarachinta, AK Chettupalli
Year: 2022
Citations: 23
Title: Nanostructured lipid carriers to enhance the bioavailability and solubility of ranolazine: Statistical optimization and pharmacological evaluations
Authors: A Unnisa, AK Chettupalli, RS Alazragi, W Alelwani, AM Bannunah, …
Year: 2023
Citations: 17
Title: Development and validation of glibenclamide in nanoemulsion formulation by using RP-HPLC
Authors: AB Mohd, P Swathimutyam, AP Rao, N Shastri, PV Diwan
Year: 2011
Citations: 15
Title: Method development and validation for estimation of risperidone in novel liquisolid formulation by RP-HPLC
Authors: K Sanka, S Bairi, R Gullapelli, S Bandi, AM Babu, AP Rao, PV Divana
Year: 2014
Citations: 9
Title: Formulation and evaluation of poly herbal liqui-solid compact for its anti-inflammatory effect
Authors: AK Chettupalli, RR Amara, PR Amarachinta, RM Manda, BSR Garige, …
Year: 2021
Citations: 8
Title: Development and validation of simvastatin in microemulsion formulation using RP-HPLC
Authors: C Srinivas, AB Mohd, S Huidrom, A Rao, PV Diwan
Year: 2012
Citations: 8
Title: Quality by Design approach for preparation, characterization, and statistical optimization of naproxen sodium-loaded ethosomes via transdermal route
Authors: AK Chettupalli, S Ajmera, PR Amarachinta, RM Manda, RK Jadi
Year: 2023
Citations: 6
Title: Preclinical evaluation of polyherbal formulations: hypoglycemic activity in rats
Authors: PR Amarachinta, KJ Kaiser Jamil
Year: 2012
Citations: 6
Title: Letter to Editor: Recent Advancement in Blood Cancer Research and Management
Authors: MA Jahangir, AP Rao
Year: 2019
Citations: 4

Vibhuti Shah | Medicine and Dentistry | Best Researcher Award

Published on 11/03/202511/03/2025 by NESIN Awards

Dr. Vibhuti Shah | Medicine and Dentistry | Best Researcher Award

MD, FRCPC at Mount Sinai Hospital, Canada

Dr. Vibhuti Shah is a distinguished neonatologist, clinical epidemiologist, and professor at the University of Toronto, with over two decades of expertise in pediatric research. She serves as Chair of the Research Ethics Board at Mount Sinai Hospital and has played a pivotal role in advancing neonatal care through her extensive research. Holding multiple prestigious qualifications, including an MSc in Clinical Epidemiology, MRCPCH (UK), and FRCPC (Canada), she has been recognized internationally for her contributions, receiving awards such as the Patil Award (AMEE, UK) and invitations from JAMA’s “Author in the Room” program. Dr. Shah’s leadership in academia and research ethics, combined with her mentorship of future medical professionals, underscores her commitment to improving neonatal outcomes. Her work has significantly impacted clinical guidelines and patient care, making her a strong contender for the Best Researcher Award. Her dedication to research excellence continues to shape advancements in neonatology and pediatrics globally.

Professional Profile

Education

Dr. Vibhuti Shah has an extensive educational background in medicine, pediatrics, and clinical research. She earned her MBBS from the University of Bombay in 1982, followed by a Diploma in Child Health (DCH) in 1986 and an MD in Pediatrics in 1987. Further advancing her expertise, she obtained the prestigious MRCP (UK) in 1994 and MRCPCH (UK) in 1997, signifying her specialization in pediatrics and child health. She later achieved the FRCPC (Paediatrics) from the Royal College of Physicians and Surgeons of Canada in 2005, cementing her reputation in the field. Committed to research excellence, Dr. Shah pursued an MSc in Clinical Epidemiology and Healthcare Research at the University of Toronto in 2007. Her extensive training includes fellowships in neonatology and perinatal medicine in India, the UK, and Canada. This strong academic foundation has enabled her to contribute significantly to neonatal research, ethics, and healthcare advancements.

Professional Experience

Dr. Vibhuti Shah has an extensive professional career spanning clinical practice, research, and academic leadership in neonatology and pediatrics. She is a Professor in the Department of Pediatrics and the Institute of Health Policy, Management, and Evaluation at the University of Toronto and a Staff Neonatologist and Clinical Epidemiologist at Mount Sinai Hospital. She also chairs the Research Ethics Board at Mount Sinai Hospital and Humber River Hospital, overseeing research integrity and compliance. Previously, she served as Interim Co-Chair of the Research Ethics Board and held clinical fellowships in neonatology in Canada, the UK, and India. She has been an Associate Member of the School of Graduate Studies at the University of Toronto since 2008 and has contributed significantly to mentoring and training medical professionals. With decades of experience in research, clinical care, and ethics, Dr. Shah has played a vital role in shaping neonatal healthcare policies and advancing pediatric medicine.

Research Interest

Dr. Vibhuti Shah’s research interests focus on neonatal-perinatal medicine, clinical epidemiology, and healthcare ethics, with a strong emphasis on improving neonatal outcomes through evidence-based interventions. She has conducted extensive research on pain management in neonates, neonatal resuscitation, and perinatal care strategies, contributing to clinical guidelines that enhance patient care. Her work in clinical epidemiology involves evaluating healthcare interventions, systematic reviews, and meta-analyses to improve neonatal and pediatric care practices. As Chair of the Research Ethics Board at Mount Sinai Hospital, she is also deeply engaged in research ethics, ensuring the ethical conduct of clinical trials and healthcare studies. Additionally, Dr. Shah has been involved in health policy research, focusing on optimizing neonatal healthcare delivery. Her contributions, recognized by prestigious international awards, continue to shape neonatal clinical practices and influence medical education, making a significant impact on global pediatric research and patient care.

Award and Honor

Dr. Vibhuti Shah has received numerous prestigious awards and honors in recognition of her contributions to neonatal research, medical education, and clinical epidemiology. Internationally, she was awarded the Patil Award by the Association for Medical Education in Europe (AMEE, UK) for her work in teaching and learning. She was also selected for the Mid-Atlantic Conference on Perinatal Research in both 2005 and 2006, receiving travel awards for her groundbreaking research in neonatology. In 2006, she was honored with the Thomas Jefferson Honorarium and Speakership for her clinical research contributions. Additionally, she was selected by the Journal of the American Medical Association (JAMA) for its “Author in the Room” program, recognizing her impactful research on neonatal pain management. These accolades underscore Dr. Shah’s exceptional leadership, innovation, and commitment to advancing neonatal healthcare, making her a highly respected figure in the global pediatric research community.

Research Skill

Dr. Vibhuti Shah possesses a diverse set of research skills that have significantly contributed to advancements in neonatal-perinatal medicine and clinical epidemiology. She is highly proficient in clinical trial design, systematic reviews, meta-analyses, and evidence-based medicine, ensuring that neonatal healthcare practices are guided by robust scientific evidence. Her expertise in biostatistics and data analysis allows her to critically evaluate healthcare interventions and contribute to policy changes. As Chair of the Research Ethics Board at Mount Sinai Hospital, she has extensive experience in research ethics, protocol development, and regulatory compliance, ensuring the integrity of clinical studies. Dr. Shah is also skilled in grant writing, peer-reviewed publishing, and mentoring young researchers, fostering innovation in pediatric research. Her ability to integrate clinical epidemiology with neonatology has led to impactful findings that have shaped neonatal care guidelines, demonstrating her strong analytical, ethical, and leadership capabilities in research.

Conclusion

Dr. Vibhuti Shah is an exceptionally strong candidate for the Best Researcher Award due to her outstanding contributions to neonatology, clinical epidemiology, and medical ethics research. While she has already earned international recognition, additional emphasis on research impact metrics and global collaboration could make her case even stronger.

Publications Top Noted

Shah VK, Firmal P, Alam A, Ganguly D, Chattopadhyay S. (2020). Overview of immune response during SARS-CoV-2 infection: lessons from the past. Frontiers in Immunology, 11, 1949. https://pubmed.ncbi.nlm.nih.gov/32849654
Cited by: 548
Firmal P, Shah VK, Chattopadhyay S. (2020). Insight into TLR4-mediated immunomodulation in normal pregnancy and related disorders. Frontiers in Immunology, 11, 807.
Cited by: 105
Pant R, Firmal P, Shah VK, Alam A, Chattopadhyay S. (2021). Epigenetic regulation of adipogenesis in development of metabolic syndrome. Frontiers in Cell and Developmental Biology, 8, 619888.
Cited by: 52
Choksi A, Parulekar A, Pant R, Shah VK, Nimma R, Firmal P, Singh S, et al. (2021). Tumor suppressor SMAR1 regulates PKM alternative splicing by HDAC6-mediated deacetylation of PTBP1. Cancer & Metabolism, 9, 1-17.
Cited by: 23
Alam A, Taye N, Patel S, Thube M, Mullick J, Shah VK, Pant R, et al. (2019). SMAR1 favors immunosurveillance of cancer cells by modulating calnexin and MHC I expression. Neoplasia, 21(10), 945-962.
Cited by: 19
Firmal P, Shah VK, Pant R, Chattopadhyay S. (2022). RING finger protein TOPORS modulates the expression of tumor suppressor SMAR1 in colorectal cancer via the TLR4‐TRIF pathway. Molecular Oncology, 16(7), 1523-1540.
Cited by: 6
Pant R, Alam A, Choksi A, Shah VK, Firmal P, Chattopadhyay S. (2021). Chromatin remodeling protein SMAR1 regulates adipogenesis by modulating the expression of PPARγ. Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids.
Cited by: 3
Sharma A, Garg S, Shah V, Agrawal P, Lohan P. (2015). Basics of design: lessons from walled city of Jaipur.
Cited by: 2